Skip to main content Skip to footer

New strategies for drug discovery and development

Research and development is the lifeblood of every life sciences company and today, companies need to accelerate their discovery efforts. 
Cognizant’s digital solutions are focused on improving your discovery and preclinical processes, and optimizing your product development strategies. Count on us to address the full discovery lifecycle with offerings that include re-engineering and consulting services, lab automation services, biomarker research and knowledge process outsourcing. 
The result is faster drug discovery and better patient outcomes.
Learn more about our Life Sciences solutions for your business.

Related thinking

Agile drug development required in a new age of urgency

It’s time to reconsider the current paradigm of drug development, clinical trials and regulatory approvals.

vial of blood
The future of infectious disease

For all its horrors, the COVID-19 pandemic may be the agent that takes us to a better place.

AI regulation is coming to life sciences: Three steps to take now

To maximize the value of artificial intelligence and machine learning for patients, healthcare providers together with life sciences enterprises must gear up to meet the continually evolving regulatory landscape.

cell structure

Featured work


AI keeps sensitive pharma information secure
staring at a slide


Data science fast-tracks cancer drug development


Analytics helps improve regulatory compliance
pharmacovigilance analytics driven


Avi Kulkarni

SVP Life Sciences Strategic Business Unit Head

Gaurav Marya

Strategic Business Unit Head & Business Unit Integration Lead, Life Sciences

Take the first step

Serving customers by looking forward as well as back is a big promise, but the power of today’s new digital capabilities is vast and growing.

Let’s talk about how digital can work for your business.